企業プロフィール

Catheter Precision 株価・ニュース・カタリスト

ティッカー:
VTAK
取引所:
NYSE
セクター:
MedTech
所在地:
United States

株価パフォーマンス

1.51 USD (+893.42%)

終値

最終更新: 2026年10月2日

2.58M USD

時価総額

株価変動の要因

最新のモニタリング対象企業ニュースは「Flyte Aviation Launches Under NYSE American Ticker “VJET”」です。対応する終値の反応はまだ確認できません。

企業概要

Cardiac Electrophysiology and Aviation Company

Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments.

VIVO Cardiac Mapping System

VIVO is a non-invasive three-dimensional mapping system used to localize the origin of ventricular arrhythmias before an electrophysiology procedure. The technology combines a standard electrocardiogram with cardiac imaging data.

LockeT Suture Retention Device

LockeT temporarily secures sutures used to close vascular access sites after catheter-based procedures. Its design distributes tension and helps clinicians find and remove the suture efficiently.

Electrophysiology Commercial Model

VIVO is sold to hospitals and electrophysiology centers, while LockeT is a single-use product that can generate recurring procedure-based demand. U.S. direct activity and international distributors support commercialization.

Private Aviation Segment

Through acquired subsidiaries, the company provides private-aircraft charter services. This segment diversifies revenue but is operationally separate from the cardiac-device business.

今後のカタリスト

    最近のニュース

    ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。